ALTRAZEAL

ALTRAZEAL TRANSFORMING POWDER DRESSING | TRANSFORMING TECHNOLOGY | TRANSFORMING WOUND CARE | TRANSFORMING LIVES

Altrazeal® is a patented powder dressing specially engineered to cover and protect the wound and to provide an ideal moist wound healing environment that supports cellular function and tissue repair. Its non-resorbable, sterile granules aggregate when hydrated with saline to form a moist, flexible, oxygen permeable film that fits and seals the wound. Powder may be added from time to time and secured with simple secondary dressings for more exudative wounds, without requiring primary dressing changes. As the wound heals, the powder dries and flakes off like a scab. Disclaimer: Please see the Altrazeal Instructions for Use for a complete listing of uses, warnings and precautions.

DATA RELEASE: ALTRAZEAL IN SICKLE CELL ASSOCIATED WOUNDSSickle cell associated wounds are notoriously difficult to heal ...
09/17/2025

DATA RELEASE: ALTRAZEAL IN SICKLE CELL ASSOCIATED WOUNDS

Sickle cell associated wounds are notoriously difficult to heal as the treatment involves various challenges including pain, inflammation, chronicity and vascular insufficiency. At the Symposium on Advanced Wound Care (SAWC) Spring 2023 Meeting, Alisha Oropallo, MD and Amit Rao, MD from Northwell Health presented a case series illustrating the use of Altrazeal in sickle cell ulcers.

The study concluded that the implementation of Altrazeal showed significant improvement in the healing trajectory for both patients within a short period of time. The patients also reported reduced pain post-treatment.

To learn more about Altrazeal, click here: www.altrazeal.com

DATA RELEASE: COMPLEX FULL THICKNESS TRAUMATIC WOUNDSA study presented by Dr. Jonathan Saxe, Vice Chair of Surgery, Asce...
09/15/2025

DATA RELEASE: COMPLEX FULL THICKNESS TRAUMATIC WOUNDS

A study presented by Dr. Jonathan Saxe, Vice Chair of Surgery, Ascension St. Vincent Medical Center and Medical Director, Altrazeal Life Sciences Inc., at the Medical Technology Enterprise Consortium (MTEC) Annual Membership Meeting evaluated how Altrazeal helped treat 10 patients with complex, full thickness traumatic wounds with elements of exposed bones, tendons and muscles. A marked acceleration in healing with reduced frequency of dressing changes relative to the standard of care was achieved in all 10 cases.

The A-Team invites you to booth  #203 at   to learn about how Altrazeal can be used in the treatment of complex, painful...
09/05/2025

The A-Team invites you to booth #203 at to learn about how Altrazeal can be used in the treatment of complex, painful, difficult to dress wounds.

Thank you to all those who stopped by our booth today. We look forward to collaborating with you all to !

Thank you to everyone who visited our booth at hashtag  to learn more about how Altrazeal® can support the treatment of ...
08/11/2025

Thank you to everyone who visited our booth at hashtag to learn more about how Altrazeal® can support the treatment of complex, difficult-to-dress wounds in low-resource combat settings.

If we missed you and you would like to learn more, please feel free to leave a comment below or send us a direct message. We look forward to continuing the conversation as we work together to hashtag .

Military Health

hashtag hashtag hashtag hashtag hashtag hashtag hashtag

The A-team is excited to be at the Military Health System Research Symposium (MHSRS) 2025, connecting with military heal...
08/05/2025

The A-team is excited to be at the Military Health System Research Symposium (MHSRS) 2025, connecting with military healthcare providers, researchers, and innovators dedicated to advancing care for those who serve.

Visit booth #1020 to learn how Altrazeal can help improving outcomes in combat casualty care and complex wound management.

We look forward to connecting with you to !

Data Release: Navy Funded RCT in Diabetic Foot UlcersDr. Lawrence Lavery, DPM MPH, founding member of the International ...
07/29/2025

Data Release: Navy Funded RCT in Diabetic Foot Ulcers

Dr. Lawrence Lavery, DPM MPH, founding member of the International Working Group on the Diabetic Foot (IWGDF) and Professor at UT Health San Antonio , presented the results of a DoD-funded, 11-site Phase IV randomized controlled trial (n=135) comparing Altrazeal to standard of care at the 2025 American Diabetes Association Scientific Sessions.

Altrazeal patients recorded:

✔️ 51% greater weekly wound area reduction (p=0.002)
✔️ 66% fewer dressing changes
✔️ 32% fewer debridements (p=0.01)
✔️ 89% rated Altrazeal “much better” than previous dressings
✔️ No dressing-related adverse events

We're grateful for Dr. Lavery’s clinical leadership and his continued efforts to expand access to meaningful innovation in wound care.

07/20/2025

Leading with a Purpose - Our CEO’s personal journey with Altrazeal

We’re proud to share that our CEO, Vaidehi Shah, was invited to speak at the Advanced Wound Care Summit in Boston, MA, on a global panel titled “Wound Care Success Stories.”

The AWC Summit brings together the brightest minds in wound care innovation from around the world—and Vai’s journey stood out.

During the session, she shared:

✅ How her career and education shaped her path to becoming CEO
✅ The biggest challenges she faced leading Altrazeal
✅ Her advice for fellow entrepreneurs stepping into leadership roles

Hear more about how Vai’s personal and professional journey helped drive Altrazeal’s growth and success in the video below.

BREAKING NEWS - Dr. Lawrence Lavery, DPM, MPH presented Altrazeal's DFU RCT data at the American Diabetes Association An...
07/17/2025

BREAKING NEWS - Dr. Lawrence Lavery, DPM, MPH presented Altrazeal's DFU RCT data at the American Diabetes Association Annual Meeting!

In a multi-center randomized controlled trial (n=135, across 11 sites), Altrazeal significantly outperformed standard of care:

- 55% greater rate of wound area reduction (p=0.002)
- 67% fewer dressing changes per subject (p

Happy Independence Day!!!
07/04/2025

Happy Independence Day!!!

Our CEO, Vaidehi Shah, is invited to present at MedTech World, Bay Area, California on June 27th, 2025!
06/26/2025

Our CEO, Vaidehi Shah, is invited to present at MedTech World, Bay Area, California on June 27th, 2025!

Our CEO, Vaidehi Shah, and COO, Anish shah, were invited to present at the Innovator Summit in Silicon Valley. We are ho...
06/25/2025

Our CEO, Vaidehi Shah, and COO, Anish shah, were invited to present at the Innovator Summit in Silicon Valley. We are honored to contribute to conversations shaping the future of healthcare.

ALTRAZEAL Life Sciences Inc. is proud to be one of 65 companies selected from over 1,400 global applicants to join the MedTech Innovator 2025 cohort!


BREAKING NEWS - Altrazeal is one of 65, of 1,400 companies invited to join MedTech Innovator, the world’s largest accele...
06/23/2025

BREAKING NEWS - Altrazeal is one of 65, of 1,400 companies invited to join MedTech Innovator, the world’s largest accelerator of medical device, digital health, and diagnostic companies. Many thanks to the mentors, investors, and reviewers who are supporting our vision. Together, let's !

Address

4410 Beltway Drive
Addison, TX
75001

Alerts

Be the first to know and let us send you an email when ALTRAZEAL posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ALTRAZEAL:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram